Clinical Report: New leadership expands Huntington’s Disease Center of Excellence at UCI Health

Overview

The UCI Health Huntington’s Disease Center of Excellence is under new leadership, focusing on multidisciplinary approaches and innovative research. Key initiatives include a Rare Neurological Diseases Multidisciplinary Clinic and participation in clinical trials.

Background

Huntington's disease is a progressive neurodegenerative disorder that significantly impacts patients and their families. Centers of Excellence provide specialized care and support for managing the complexities of this condition.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• The UCI Health Huntington’s Disease Center of Excellence has been designated by the Huntington’s Disease Society of America since 2019.
• Multidisciplinary care includes genetic counseling, specialty neurologic care, and support from rehabilitation therapists and social workers.
• A new Rare Neurological Diseases Multidisciplinary Clinic allows patients to see multiple specialists in a single visit.
• Collaboration with community partners has improved access to resources and support services.
• Ongoing research includes participation in the global Enroll-HD study and a $12 million CIRM-funded stem cell clinical trial.

Clinical Implications

The establishment of multidisciplinary clinics can streamline patient care and improve access to specialized services. Ongoing research initiatives are essential for developing innovative treatment options for Huntington's disease.

Conclusion

The advancements at the UCI Health Huntington’s Disease Center of Excellence represent a significant step forward in the care and management of Huntington's disease, emphasizing the importance of coordinated, multidisciplinary approaches.

Related Resources & Content

1. UCI Health, UCI Health makes history in 2025, 2025 -- UCI Health makes history in 2025
2. UCI Health, UCI Health takes national lead in combating diabetes epidemic, 2025 -- UCI Health takes national lead in combating diabetes epidemic
3. UCI Health, Chad Lefteris named among top U.S. academic medical center CEOs, 2025 -- Chad Lefteris named among top U.S. academic medical center CEOs
4. uci health — UCI Health celebrates more than 215 Physicians of Excellence
5. Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease | Neurology Clinical Practice
6. Huntington Disease
7. Predictive testing for Huntington’s disease in a digital age; patient power with potential pitfalls | European Journal of Human Genetics
8. These highlights do not include all the information needed to use TETRABENAZINE TABLETS safely and effectively. See full prescribing information for TETRABENAZINE TABLETS. TETRABENAZINE tablets, for oral useInitial U.S. Approval: 2008
9. Frontiers | Efficacy and safety of vesicular monoamine transporter 2 inhibitors for Huntington’s disease chorea based on network meta-analysis
10. Huntington's Disease Association - Professional guidelines
11. uniQure annoncerer positive resultater fra det pivotale fase I/II-studie af AMT-130 hos patienter med Huntingtons sygdom - International Huntington Association
12. Summary of Clinical Trial Results
13. PTC518 PIVOT-HD Study Achieves Primary Endpoint | PTC Therapeutics.